Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shh-Yap signaling controls hepatic ductular reactions in CCl4 -induced liver injury. | Environ Toxicol | 2021 | 32996673 | PubTator, text mining | PubMed |
| 6-Gingerol suppresses tumor cell metastasis by increasing YAPser127 phosphorylation in renal cell carcinoma. | J Biochem Mol Toxicol | 2021 | 32926756 | PubTator, text mining | PubMed |
| SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling. | Protein Cell | 2021 | 32661924 | PubTator, text mining | PubMed |
| Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment. | Semin Cancer Biol | 2021 | 31883910 | PubTator, text mining | PubMed |
| Knockout of LATS1 induces neoplastic phenotype in hepatic oval cells. | Transl Cancer Res | 2020 | 35117720 | PubTator, text mining | PubMed |
| DAB2 suppresses gastric cancer migration by regulating the Wnt/β-catenin and Hippo-YAP signaling pathways. | Transl Cancer Res | 2020 | 35117462 | PubTator, text mining | PubMed |
| Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K/mTOR dual targeted therapy. | Mol Biomed | 2020 | 35006410 | PubTator, text mining | PubMed |
| Reprogramming of Ovarian Granulosa Cells by YAP1 Leads to Development of High-Grade Cancer with Mesenchymal Lineage and Serous Features. | Sci Bull (Beijing) | 2020 | 34888112 | PubTator, text mining | PubMed |
| lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p. | Front Oncol | 2020 | 33708618 | PubTator, text mining | PubMed |
| Cardioprotective Effect of Echinatin Against Ischemia/Reperfusion Injury: Involvement of Hippo/Yes-Associated Protein Signaling. | Front Pharmacol | 2020 | 33584269 | PubTator, text mining | PubMed |
| LncRNA LINC00511 Acts as an Oncogene in Colorectal Cancer via Sponging miR-29c-3p to Upregulate NFIA. | Onco Targets Ther | 2020 | 33536761 | PubTator, text mining | PubMed |
| Long Noncoding RNAs in the Metastasis of Oral Squamous Cell Carcinoma. | Front Oncol | 2020 | 33520725 | PubTator, text mining | PubMed |
| Long Non-Coding RNA MAPK8IP1P2 Inhibits Lymphatic Metastasis of Thyroid Cancer by Activating Hippo Signaling via Sponging miR-146b-3p. | Front Oncol | 2020 | 33489905 | PubTator, text mining | PubMed |
| NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein. | Front Oncol | 2020 | 33489890 | PubTator, text mining | PubMed |
| Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma. | Transl Androl Urol | 2020 | 33457229 | PubTator, text mining | PubMed |
| The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth. | Cancers (Basel) | 2020 | 33419295 | PubTator, text mining | PubMed |
| The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma. | Am J Cancer Res | 2020 | 33415007 | PubTator, text mining | PubMed |
| MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2. | Oxid Med Cell Longev | 2020 | 33414893 | PubTator, text mining | PubMed |
| Downregulation of circFASTKD1 ameliorates myocardial infarction by promoting angiogenesis. | Aging (Albany NY) | 2020 | 33411690 | PubTator, text mining | PubMed |
| Chemical Decorations of "MARs" Residents in Orchestrating Eukaryotic Gene Regulation. | Front Cell Dev Biol | 2020 | 33409278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=69